ADVERTISEMENT
4 /5 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Lonza boosts biologics in New Hampshire

by Rick Mullin
May 13, 2018 | APPEARED IN VOLUME 96, ISSUE 20

 

Lonza will expand its Portsmouth, N.H., biologics manufacturing site with the addition of multiple 6,000-L bioreactors for mammalian cell production as well as cell therapy suites that can handle projects from Phase I through commercial-scale manufacturing. The new facilities will employ single-use bioreactor technology. Lonza, an early entrant into contract biologics manufacturing, has operated the Portsmouth plant since the late 1990s.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment